Literature DB >> 32186357

Melanoma Cell Membrane Biomimetic Versatile CuS Nanoprobes for Homologous Targeting Photoacoustic Imaging and Photothermal Chemotherapy.

Minliang Wu1, Tianxiao Mei2, Chenyu Lin2, Yuchong Wang1, Jingyao Chen2, Wenjun Le2, Mengyan Sun1, Jianguo Xu1, Haiying Dai1, Yifan Zhang2, Chunyu Xue1, Zhongmin Liu2, Bingdi Chen2.   

Abstract

Modulating the surface properties of nanoparticles (NPs) is an important approach to accomplish immune escape, prolonged the blood retention time, and enhance the ability of targeted drug delivery. The camouflage of cancer cell membrane onto nanoparticles has been proved to be an ideal approach to enhance active targeting ability of NPs. Herein, we isolated the membrane of melanoma cells to coat doxorubicin (DOX) and indocyanine green (ICG)-loaded hollow copper sulfide NPs (ID-HCuSNP@B16F10) for targeted photothermal therapy, photoacoustic imaging, and chemotherapy. A remarkable in vitro anticancer effect after irradiation and homologous targeting can be observed in B16F10 cells after the treatment of ID-HCuSNP@B16F10. Moreover, ID-HCuSNP@B16F10 exhibits excellent photothermal effect in melanoma animal models and achieves a high tumor ablation rate. This biomimetic system can realize high drug loading efficiency, enhanced targeting ability, and ideal antitumor efficiency.

Entities:  

Keywords:  CuS; homologous Targeting; melanoma; photoacoustic imaging; photothermal therapy

Mesh:

Substances:

Year:  2020        PMID: 32186357     DOI: 10.1021/acsami.9b23177

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  10 in total

Review 1.  Metal-based nanoparticles, sensors, and their multifaceted application in food packaging.

Authors:  Antul Kumar; Anuj Choudhary; Harmanjot Kaur; Sahil Mehta; Azamal Husen
Journal:  J Nanobiotechnology       Date:  2021-08-26       Impact factor: 10.435

2.  Plasma Membrane-Derived Liposomes Exhibit Robust Antiviral Activity against HSV-1.

Authors:  Ilina Bhattacharya; Tejabhiram Yadavalli; David Wu; Deepak Shukla
Journal:  Viruses       Date:  2022-04-12       Impact factor: 5.818

3.  Unleashing the potential of cell membrane-based nanoparticles for COVID-19 treatment and vaccination.

Authors:  Miguel Pereira-Silva; Gaurav Chauhan; Matthew D Shin; Clare Hoskins; Marc J Madou; Sergio O Martinez-Chapa; Nicole F Steinmetz; Francisco Veiga; Ana Cláudia Paiva-Santos
Journal:  Expert Opin Drug Deliv       Date:  2021-06-06       Impact factor: 6.648

4.  Intelligent phototriggered nanoparticles induce a domino effect for multimodal tumor therapy.

Authors:  Xiao Xu; Chao Han; Can Zhang; Dan Yan; Chunling Ren; Lingyi Kong
Journal:  Theranostics       Date:  2021-04-19       Impact factor: 11.556

5.  Polydopamine-Coated Laponite Nanoplatforms for Photoacoustic Imaging-Guided Chemo-Phototherapy of Breast Cancer.

Authors:  Renna Liu; Fanli Xu; Lu Wang; Mengxue Liu; Xueyan Cao; Xiangyang Shi; Rui Guo
Journal:  Nanomaterials (Basel)       Date:  2021-02-04       Impact factor: 5.076

Review 6.  Bacteria-Based Cancer Immunotherapy.

Authors:  Xuehui Huang; Jingmei Pan; Funeng Xu; Binfen Shao; Yi Wang; Xing Guo; Shaobing Zhou
Journal:  Adv Sci (Weinh)       Date:  2021-02-10       Impact factor: 16.806

7.  Cell membrane camouflaged biomimetic nanoparticles: Focusing on tumor theranostics.

Authors:  Li Zhu; Yuan Zhong; Shuai Wu; Meng Yan; Yu Cao; Nianlian Mou; Guixue Wang; Da Sun; Wei Wu
Journal:  Mater Today Bio       Date:  2022-03-01

Review 8.  Engineered Cell Membrane-Derived Nanocarriers: The Enhanced Delivery System for Therapeutic Applications.

Authors:  Biao Yu; Xu Xue; Zhifeng Yin; Liehu Cao; Mengmeng Li; Jianping Huang
Journal:  Front Cell Dev Biol       Date:  2022-02-28

Review 9.  Emerging Nanotherapeutic Approaches to Overcome Drug Resistance in Cancers with Update on Clinical Trials.

Authors:  Syed Nasir Abbas Bukhari
Journal:  Pharmaceutics       Date:  2022-04-15       Impact factor: 6.525

Review 10.  High Drug-Loading Nanomedicines for Tumor Chemo-Photo Combination Therapy: Advances and Perspectives.

Authors:  Ya Wang; Yujie Zhang; Xiaojiang Zhang; Zhe Zhang; Junjun She; Daocheng Wu; Wei Gao
Journal:  Pharmaceutics       Date:  2022-08-19       Impact factor: 6.525

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.